For the Inventor, By the Inventor

Enter assignee name

San Diego, CA, United States of America

Cytori Therapeutics, Inc.

Calculating rank

USPTO Granted Patents = 38

% Expired Patents = 68.4

CIPO Patents = 2

EPO Patents = 18

Trademarks = 11

Forward Citations = 1,808

Loading Chart...

Loading Chart...

21 inventors (with patents filed for the assignee):

John K Fraser (35 out of 35 patents)

Marc H Hedrick (33 out of 36 patents)

Eric Daniels (10 out of 10 patents)

4. Ronda Elizabeth Schreiber (7 out of 10 patents)

5. Michael J Schulzki (5 out of 5 patents)

6. Bobby Byrnes (5 out of 5 patents)

7. Isabella Wulur (5 out of 5 patents)

8. Grace A Carlson (5 out of 17 patents)

9. Susan Riley (4 out of 7 patents)

10. Brian M Strem (2 out of 3 patents)

11. Zeni Alfonso (2 out of 2 patents)

12. James Peter Amis (2 out of 9 patents)

13. Robert Keith Shanahan (1 out of 3 patents)

14. G Bryan Cornwall (1 out of 24 patents)

15. Min Zhu (1 out of 9 patents)

Core Competencies:

Adipose Derived Regenerative Cells

Epithelialization

Neodermis Formation

Cardiovascular Conditions

Ischemic Wound

Autologous Fat Transfer

Musculoskeletal Disorders

Liver Injury

Peripheral Vascular Disease

Wound Healing

Stem Cells

38 patents: Sort by Forward Citations

1. 10119113 - Systems for isolating and using clinically safe adipose derived regenerative cells (2018-11-06),

2. 9872877 - Methods of using regenerative cells to promote epithelialization or neodermis formation (2018-01-23),

3. 9849149 - Methods of using regenerative cells in the treatment of erectile dysfunction (2017-12-26),

4. 9597395 - Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions (2017-03-21),

5. 9511096 - Methods of using regenerative cells to treat an ischemic wound (2016-12-06),

6. 9511094 - Methods of using regenerative cells in the treatment of stroke and related diseases and disorders (2016-12-06),

7. 9504718 - Methods of using adipose derived regenerative cells in the treatment of renal diseases and disorders (2016-11-29),

8. 9504716 - Methods of using adipose derived regenerative cells to promote restoration of intevertebral disc (2016-11-29),

9. 9492483 - Methods of using regenerative cells to treat a burn (2016-11-15),

10. 9486484 - Methods of using adipose tissue-derived cells in the treatment of the lymphatic system and malignant disease (2016-11-08),

11. 9480718 - Methods of using adipose-derived regenerative cells in the treatment of peripheral vascular disease and related disorders (2016-11-01),

12. 9463203 - Methods of using regenerative cells in the treatment of cartilage defects (2016-10-11),

13. 9198937 - Adipose-derived regenerative cells for treating liver injury (2015-12-01),

14. 8883499 - Systems and methods for isolating and using clinically safe adipose derived regenerative cells (2014-11-11),

15. 8784801 - Methods of using adipose tissue-derived cells in the treatment of the lymphatic system and malignant disease (2014-07-22),

Company Overview

Cytori Therapeutics, Inc. is a biotechnology company based in San Diego, California, specializing in regenerative medicine. The company focuses on developing and commercializing innovative therapies that harness the power of adipose-derived stem and regenerative cells. Cytori's research primarily targets applications in areas such as wound healing, cardiovascular health, and aesthetic medicine, aiming to improve patient outcomes through advanced cellular therapies and medical devices.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

38 Patents

#164 in San Diego, CA

#2,133 in California

#9,035 in US

#17,870 in the World

San Diego, CA, United States of America

Cytori Therapeutics, Inc.

Forward Citations = 1,808

21 inventors:

John K Fraser (35 out of 35 patents)

Marc H Hedrick (33 out of 36 patents)

Eric Daniels (10 out of 10 patents)

4. Ronda Elizabeth Schreiber (7 out of 10 patents)

5. Michael J Schulzki (5 out of 5 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Cytori Therapeutics, Inc.. Retrieved from https://idiyas.com/company/cytori-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…